Goldman Slashes Guidant Rating

Analyst Lawrence Keusch says the medical-device maker's base business is seeing tougher competition and could further erode

Goldman Sachs removed Guidant Corp. (GDT ) from its recommended list and now rates the shares market perform. Goldman also trimmed estimates.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.